Japan Embolic Protection Devices Market

ID: MRFR/HC/52834-HCR
200 Pages
Nidhi Mandole
Last Updated: February 06, 2026
Japan Embolic Protection Devices Market Research Report By Type (Distal Filter Device, Distal Occlusion Device, Proximal Occlusion Device), By Material (Nitinol, Polyurethane), By Usage (Disposable Device, Reusable Device), By Application (Cardiovascular Diseases, Neurovascular Diseases, Peripheral Vascular Diseases) andBy End User (Hospitals and Clinics, Ambulatory Surgical Centers, Specialty Centers) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Japan Embolic Protection Devices Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)9.35%
2024 Market Size$ 14.31 Million
2025 Market Size$ 15.65 Million
2035 Market Size$ 38.24 Million

Key Players

Medtronic
Boston Scientific
Abbott Laboratories
Terumo Corporation
Cardinal Health
B. Braun Melsungen AG
Trends
  • Technological Advancements
  • Regulatory Support
  • Focus on Patient Outcomes
Opportunities
  • Increasing Healthcare Expenditure
  • Technological Innovations in Device Design
  • Regulatory Framework and Approval Processes
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Pharmaceutical, BY Type (USD Million)
      1. 4.1.1 Distal Filter Device
      2. 4.1.2 Distal Occlusion Device
      3. 4.1.3 Proximal Occlusion Device
    2. 4.2 Pharmaceutical, BY Material (USD Million)
      1. 4.2.1 Nitinol
      2. 4.2.2 Polyurethane
    3. 4.3 Pharmaceutical, BY Usage (USD Million)
      1. 4.3.1 Disposable Device
      2. 4.3.2 Re-Usable Device
    4. 4.4 Pharmaceutical, BY Application (USD Million)
      1. 4.4.1 Cardiovascular Diseases
      2. 4.4.2 Coronary Artery Diseases
      3. 4.4.3 Trans Catheter Aortic Valve Replacement
      4. 4.4.4 Saphenous Vein Graft Diseases
      5. 4.4.5 Neurovascular Diseases
      6. 4.4.6 Peripheral Vascular Diseases
    5. 4.5 Pharmaceutical, BY End-User (USD Million)
      1. 4.5.1 Hospitals & Clinics
      2. 4.5.2 Ambulatory Surgical Centers
      3. 4.5.3 Specialty Centers
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Medtronic (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Boston Scientific (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Abbott Laboratories (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Terumo Corporation (JP)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Cardinal Health (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 B. Braun Melsungen AG (DE)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Edwards Lifesciences Corporation (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Stryker Corporation (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 JAPAN MARKET ANALYSIS BY TYPE
    3. 6.3 JAPAN MARKET ANALYSIS BY MATERIAL
    4. 6.4 JAPAN MARKET ANALYSIS BY USAGE
    5. 6.5 JAPAN MARKET ANALYSIS BY APPLICATION
    6. 6.6 JAPAN MARKET ANALYSIS BY END-USER
    7. 6.7 KEY BUYING CRITERIA OF PHARMACEUTICAL
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF PHARMACEUTICAL
    10. 6.10 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
    12. 6.12 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
    13. 6.13 PHARMACEUTICAL, BY TYPE, 2024 (% SHARE)
    14. 6.14 PHARMACEUTICAL, BY TYPE, 2024 TO 2035 (USD Million)
    15. 6.15 PHARMACEUTICAL, BY MATERIAL, 2024 (% SHARE)
    16. 6.16 PHARMACEUTICAL, BY MATERIAL, 2024 TO 2035 (USD Million)
    17. 6.17 PHARMACEUTICAL, BY USAGE, 2024 (% SHARE)
    18. 6.18 PHARMACEUTICAL, BY USAGE, 2024 TO 2035 (USD Million)
    19. 6.19 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
    20. 6.20 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
    21. 6.21 PHARMACEUTICAL, BY END-USER, 2024 (% SHARE)
    22. 6.22 PHARMACEUTICAL, BY END-USER, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY MATERIAL, 2025-2035 (USD Million)
      3. 7.2.3 BY USAGE, 2025-2035 (USD Million)
      4. 7.2.4 BY APPLICATION, 2025-2035 (USD Million)
      5. 7.2.5 BY END-USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

Japan Pharmaceutical Market Segmentation

Pharmaceutical By Type (USD Million, 2025-2035)

  • Distal Filter Device
  • Distal Occlusion Device
  • Proximal Occlusion Device

Pharmaceutical By Material (USD Million, 2025-2035)

  • Nitinol
  • Polyurethane

Pharmaceutical By Usage (USD Million, 2025-2035)

  • Disposable Device
  • Re-Usable Device

Pharmaceutical By Application (USD Million, 2025-2035)

  • Cardiovascular Diseases
  • Coronary Artery Diseases
  • Trans Catheter Aortic Valve Replacement
  • Saphenous Vein Graft Diseases
  • Neurovascular Diseases
  • Peripheral Vascular Diseases

Pharmaceutical By End-User (USD Million, 2025-2035)

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Specialty Centers

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035